Human CCR2 PE-conjugated Antibody
| Name | Human CCR2 PE-conjugated Antibody |
|---|---|
| Supplier | R&D Systems |
| Catalog | FAB151P |
| Prices | $129.00, $329.00 |
| Sizes | 25 tests, 100 tests |
| Host | Mouse |
| Isotype | IgG 2B |
| Clone | 48607 |
| Applications | FC |
| Species Reactivities | Human |
| Antigen | NS0 mouse myeloma cell line transfected with human CCR2 Met1-Leu360 Accession # NP_001116868 |
| Purity/Format | Protein A or G purified from ascites |
| Description | Mouse |
| Gene | Ccr2 |
| Conjugate | Phycoerythrin |
| Supplier Page | Shop |
Product images
Detection of CCR2 in Human PBMCs by Flow Cytometry. Human peripheral blood mononuclear cells (PBMCs) were stained with Mouse Anti-Human CD14 APC-conjugated Monoclonal Antibody (Catalog # FAB3832A ) and either (A) Mouse Anti-Human CCR2 PE-conjugated Monoclonal Antibody (Catalog # FAB151P) or (B) Mouse IgG 2B Phycoerythrin Isotype Control (Catalog # IC0041P ). View our protocol for Staining Membrane-associated Proteins .
Product References
Downregulation of Blood Monocyte HLA-DR in ICU Patients Is Also Present in Bone - Downregulation of Blood Monocyte HLA-DR in ICU Patients Is Also Present in Bone
Faivre V, Lukaszewicz AC, Payen D. PLoS One. 2016 Nov 28;11(11):e0164489.
Extensive Characterization and Comparison of Endothelial Cells Derived from - Extensive Characterization and Comparison of Endothelial Cells Derived from
Monsuur HN, Weijers EM, Niessen FB, Gefen A, Koolwijk P, Gibbs S, van den Broek LJ. PLoS One. 2016 Nov 30;11(11):e0167056.
Buprenorphine decreases the CCL2-mediated chemotactic response of monocytes. - Buprenorphine decreases the CCL2-mediated chemotactic response of monocytes.
Carvallo L, Lopez L, Che FY, Lim J, Eugenin EA, Williams DW, Nieves E, Calderon TM, Madrid-Aliste C, Fiser A, Weiss L, Angeletti RH, Berman JW. J Immunol. 2015 Apr 1;194(7):3246-58.
Specificity for a CCR5 Inhibitor Is Conferred by a Single Amino Acid Residue: - Specificity for a CCR5 Inhibitor Is Conferred by a Single Amino Acid Residue:
Lau G, Labrecque J, Metz M, Vaz R, Fricker SP. J Biol Chem. 2015 Apr 24;290(17):11041-51.
IL-27 in human secondary lymphoid organs attracts myeloid dendritic cells and - IL-27 in human secondary lymphoid organs attracts myeloid dendritic cells and
Morandi F, Di Carlo E, Ferrone S, Petretto A, Pistoia V, Airoldi I. J Immunol. 2014 Mar 15;192(6):2634-42.
Cross-desensitization of CCR1, but not CCR2, following activation of the formyl - Cross-desensitization of CCR1, but not CCR2, following activation of the formyl
Bednar F, Song C, Bardi G, Cornwell W, Rogers TJ. J Immunol. 2014 Jun 1;192(11):5305-13.
CX3CL1/CX3CR1 and CCL2/CCR2 chemokine/chemokine receptor complex in patients with - CX3CL1/CX3CR1 and CCL2/CCR2 chemokine/chemokine receptor complex in patients with
Falk MK, Singh A, Faber C, Nissen MH, Hviid T, Sorensen TL. PLoS One. 2014 Dec 15;9(12):e112473.
Adenovirus-engineered human dendritic cells induce natural killer cell chemotaxis - Adenovirus-engineered human dendritic cells induce natural killer cell chemotaxis
Vujanovic L, Ballard W, Thorne SH, Vujanovic NL, Butterfield LH. Oncoimmunology. 2012 Jul 1;1(4):448-457.
Thymoquinone inhibits the CXCL12-induced chemotaxis of multiple myeloma cells and - Thymoquinone inhibits the CXCL12-induced chemotaxis of multiple myeloma cells and
Badr G, Lefevre EA, Mohany M. PLoS One. 2011;6(9):e23741.
Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of - Distinct roles for CCR4 and CXCR3 in the recruitment and positioning of
Oo YH, Weston CJ, Lalor PF, Curbishley SM, Withers DR, Reynolds GM, Shetty S, Harki J, Shaw JC, Eksteen B, Hubscher SG, Walker LS, Adams DH. J Immunol. 2010 Mar 15;184(6):2886-98.